Clinical Trial Update: Efficacy and Safety of Vildagliptin Compared to Rosiglitazone in Drug Naive Patients With Type 2 Diabetes [Phase 3]

View source ↗

Summary

This Phase 3 trial comparing vildagliptin with rosiglitazone in drug-naive patients with Type 2 diabetes has completed; the update discusses efficacy and safety…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Avandia (rosiglitazone)
• Galvus (vildagliptin)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED